Allianz Asset Management
KPTI icon

Allianz Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History

Allianz Asset Management’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,948
Closed -$808K – 2023
2022
Q2 		$808K Buy
11,948
+1,016
+9% +$93.2K ﹤0.01% 1750
2022
Q1 		$1.21M Sell
10,932
-1,541
-12% -$192K ﹤0.01% 1773
2021
Q4 		$1.21M Buy
12,473
+3,610
+41% +$360K ﹤0.01% 1822
2021
Q3 		$774K Buy
8,863
+1,001
+13% +$104K ﹤0.01% 2047
2021
Q2 		$1.22M Sell
7,862
-3,857
-33% -$560K ﹤0.01% 1663
2021
Q1 		$1.85M Sell
11,719
-8,755
-43% -$1.84M ﹤0.01% 1432
2020
Q4 		$4.75M Buy
20,474
+7,486
+58% +$1.73M ﹤0.01% 1059
2020
Q3 		$2.84M Sell
12,988
-315
-2% -$77K ﹤0.01% 1147
2020
Q2 		$3.78M Buy
13,303
+6,945
+109% +$2.05M ﹤0.01% 1328
2020
Q1 		$1.83M Buy
6,358
+961
+18% +$265K ﹤0.01% 1560
2019
Q4 		$1.55M Buy
+5,397
New +$1.17M ﹤0.01% 1992
2019
Q1 		– Sell
-7,360
Closed -$1.03M – 2734
2018
Q4 		$1.03M Buy
7,360
+120
+2% +$20.2K ﹤0.01% 2016
2018
Q3 		$1.85M Buy
7,240
+652
+10% +$180K ﹤0.01% 1966
2018
Q2 		$1.68M Buy
+6,588
New +$1.63M ﹤0.01% 2013
2015
Q3 		– Sell
-6,576
Closed -$2.68M – 2373
2015
Q2 		$2.68M Sell
6,576
-3,936
-37% -$1.7M ﹤0.01% 1588
2015
Q1 		$4.83M Buy
+10,512
New +$4.53M 0.01% 1227

Other funds holding KPTI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Allianz Asset Management's KPTI Position: Q3 2022 in Review

Allianz Asset Management sold out of Karyopharm Therapeutics (KPTI) in Q3 2022, closing a stake of 11,948 shares — an estimated $808K sold.

Allianz Asset Management first reported a position in KPTI in Q1 2015 and held it in 16 quarters. The position peaked at $4.83M in Q1 2015. 147 funds tracked by Wall St. Rank hold KPTI as of Q3 2022.

  • Allianz Asset Management reported no remaining Karyopharm Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Allianz Asset Management sold 11,948 Karyopharm Therapeutics shares in Q3 2022, an estimated $808K.
  • Allianz Asset Management first reported a position in Karyopharm Therapeutics in Q1 2015 and held it in 16 quarters.
  • Allianz Asset Management's Karyopharm Therapeutics position peaked at $4.83M in Q1 2015.
  • 147 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2022.

Based on Allianz Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.